Macquarie Group Ltd. acquired a new stake in shares of LDR Holding Corp (NASDAQ:LDRH) during the second quarter, Holdings Channel reports. The fund acquired 39,475 shares of the medical device company’s stock, valued at approximately $1,459,000.

Several other institutional investors also recently made changes to their positions in the stock. Legal & General Group Plc increased its stake in shares of LDR Holding Corp by 33.4% in the first quarter. Legal & General Group Plc now owns 4,212 shares of the medical device company’s stock valued at $107,000 after buying an additional 1,055 shares during the period. Teacher Retirement System of Texas increased its stake in shares of LDR Holding Corp by 13.7% in the second quarter. Teacher Retirement System of Texas now owns 3,661 shares of the medical device company’s stock valued at $135,000 after buying an additional 441 shares during the period. BlackRock Inc. increased its stake in shares of LDR Holding Corp by 149.1% in the second quarter. BlackRock Inc. now owns 4,011 shares of the medical device company’s stock valued at $148,000 after buying an additional 2,401 shares during the period. Emerald Acquisition Ltd. bought a new stake in shares of LDR Holding Corp during the second quarter valued at about $182,000. Finally, Menta Capital LLC bought a new stake in shares of LDR Holding Corp during the first quarter valued at about $204,000.

LDR Holding Corp (NASDAQ:LDRH) opened at 36.98 on Tuesday. LDR Holding Corp has a 52 week low of $16.33 and a 52 week high of $47.12. The company has a 50-day moving average of $33.38 and a 200-day moving average of $25.47.

Several equities research analysts have issued reports on LDRH shares. Royal Bank Of Canada downgraded shares of LDR Holding Corp from an “outperform” rating to a “sector perform” rating and raised their price objective for the stock from $33.00 to $37.00 in a research report on Thursday, June 9th. Barclays PLC started coverage on shares of LDR Holding Corp in a research report on Friday, May 27th. They set an “overweight” rating and a $27.00 price objective for the company. Stephens downgraded shares of LDR Holding Corp from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, June 15th. Gabelli downgraded shares of LDR Holding Corp from a “buy” rating to a “hold” rating in a research report on Wednesday, June 8th. Finally, Piper Jaffray Cos. downgraded shares of LDR Holding Corp from an “overweight” rating to a “neutral” rating and set a $37.00 price objective for the company. in a research report on Tuesday, June 7th. Ten equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $37.73.

LDR Holding Corp Company Profile

LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine.

5 Day Chart for NASDAQ:LDRH

Want to see what other hedge funds are holding LDRH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LDR Holding Corp (NASDAQ:LDRH).

Receive News & Ratings for LDR Holding Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LDR Holding Corp and related companies with MarketBeat.com's FREE daily email newsletter.